Julie Gralow, M.D., and Eduardo Rosenblatt, M.D., are scientific co-chairs of the program. Gralow is a member of the Clinical Research Division at the Hutchinson Center, director of breast medical oncology at Seattle Cancer Care Alliance, a professor of medical oncology at the University of Washington School of Medicine, and member of the Harvard Global Task Force for Expanded Access to Cancer Care and Control in Developing Countries. Rosenblatt is a highly distinguished radiation oncologist at the IAEA's Programme of Action for Cancer Therapy (PACT) and head of the applied radiation biology and radiotherapy section in the Division of Human Health and Nuclear Sciences and Applications in Vienna.
"Supportive care and quality of life have gradually become an essential component of the knowledge and skills necessary for the practice of clinical and radiation oncologists," Rosenblatt said. "Research on these components medical, rehabilitative, psychosocial, spiritual and nursing has to follow the same strict scientific methodology as has been the norm in the basic cancer treatment disciplines. Only this will ensure the utilization of interventions supported by evidence."
Globally recognized for leading the international breast cancer clinical improvement and best practices movement, the BHGI is uniquely positioned to address this critical area of supportive care and quality of life for breast cancer patients in underserved world regions. Over the last decade, the BHGI has produced model approaches for comprehensive, resource-stratified, evidence-based consensus guidelines to effectively detect, diagnose and treat breast cancer in LMCs. These guidelines have been developed as the tangible outcomes of previous Global Summits on International Breast Health held in 2002, 2005, 2007 and 2010.
"The BHGI has offered unique contributions to breast cancer treatment around the world through its development
|Contact: Dean Forbes|
Fred Hutchinson Cancer Research Center